Cutler Group’s Arcturus Therapeutics ARCT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Hold |
0
| – | – | – | 1373 |
|
|
2023
Q1 | – | Sell |
-600
| Closed | -$10K | – | 1435 |
|
|
2022
Q4 | $10K | Sell |
600
-200
| -25% | -$3.33K | ﹤0.01% | 1268 |
|
|
2022
Q3 | $11K | Sell |
800
-7,908
| -91% | -$109K | ﹤0.01% | 1347 |
|
|
2022
Q2 | $137K | Sell |
8,708
-4,848
| -36% | -$76.3K | 0.01% | 584 |
|
|
2022
Q1 | $365K | Buy |
13,556
+11,938
| +738% | +$321K | 0.02% | 415 |
|
|
2021
Q4 | $59K | Buy |
1,618
+731
| +82% | +$26.7K | ﹤0.01% | 1134 |
|
|
2021
Q3 | $42K | Sell |
887
-2,013
| -69% | -$95.3K | ﹤0.01% | 1261 |
|
|
2021
Q2 | $98K | Buy |
2,900
+2,366
| +443% | +$80K | ﹤0.01% | 1006 |
|
|
2021
Q1 | $22K | Sell |
534
-9,966
| -95% | -$411K | ﹤0.01% | 1438 |
|
|
2020
Q4 | $455K | Buy |
10,500
+4,798
| +84% | +$208K | 0.02% | 377 |
|
|
2020
Q3 | $244K | Buy |
5,702
+1,864
| +49% | +$79.8K | 0.02% | 441 |
|
|
2020
Q2 | $179K | Buy |
3,838
+2,838
| +284% | +$132K | 0.01% | 477 |
|
|
2020
Q1 | $13K | Sell |
1,000
-200
| -17% | -$2.6K | ﹤0.01% | 1076 |
|
|
2019
Q4 | $13K | Buy |
1,200
+400
| +50% | +$4.33K | ﹤0.01% | 1187 |
|
|
2019
Q3 | $8K | Sell |
800
-100
| -11% | -$1K | ﹤0.01% | 1213 |
|
|
2019
Q2 | $8K | Buy |
+900
| New | +$8K | ﹤0.01% | 1319 |
|
|
2017
Q1 | – | Sell |
-2,007
| Closed | -$29K | – | 2767 |
|
|
2016
Q4 | $29K | Sell |
2,007
-1,440
| -42% | -$20.8K | ﹤0.01% | 1752 |
|
|
2016
Q3 | $59K | Sell |
3,447
-266
| -7% | -$4.55K | ﹤0.01% | 1352 |
|
|
2016
Q2 | $116K | Buy |
3,713
+486
| +15% | +$15.2K | 0.01% | 936 |
|
|
2016
Q1 | $85K | Buy |
3,227
+328
| +11% | +$8.64K | 0.01% | 1012 |
|
|
2015
Q4 | $127K | Buy |
+2,899
| New | +$127K | 0.01% | 921 |
|